Environmental Stressors in Disease and Implications for Human Health

October 26 – 29, 2014 │ Boston Marriott Long Wharf Hotel, Boston, MA

PPTOX IV in Endocrinology

Future Meeting Announcement - PPTOX V

The next international summit of Prenatal Programming and Toxicity (PPTOX V) will take place November 13-16, 2016, at the Kitakyushu International Conference Center in Fukuoka, Japan. For details, please visit the PPTOX V website and continue to return for updates.

Download Previous Meeting Materials

The Endocrine Society sponsored the fourth international summit of Prenatal Programming and Toxicity (PPTOX) – a conference series dedicated to cutting-edge discussion of environmental hazards during early life and long-term consequences. PPTOX is one of the premier international venues for scientists to evaluate current knowledge and guide forward momentum for this burgeoning field.

The program included topics of interest for a wide spectrum of professional backgrounds applicable to individuals interested in the developmental origins of endocrine diseases and mechanisms of developmental programming across the lifespan and between generations.

In-Training/Early Career Travel Grant Awardees

Travel grant awardees have been selected. The 20 awardees will be recognized for their exceptional research during the opening session from 6:00 - 6:45 PM, Sunday, October 26. The travel grant awardees are:

Presenting on Monday, October 27

  • Ana Maria Mora, MD, PhD

    “Prenatal exposure to manganese and neurodevelopment at 12 months of age in the ISA study”

    Poster presentation number MON-29
  • Byungmi Kim

    “Selenium altered the reproductive and developmental neurotoxicity of mercury : MOCEH (MOthers and Childrens’ Environmental Health) study”

    Poster presentation number MON-27
  • Christopher Kassotis

    “Endocrine Disrupting Activity of Hydraulic Fracturing Chemicals and Health Outcomes Following Prenatal Exposure in Mice”

    Poster presentation number MON-47 
  • Jennifer J. Adibi, MPH, ScD

    “Placental human chorionic gonadotropin is associated with sex-specific development and the response to the endocrine disruptor mono-n-butyl phthalate.”

    Poster presentation number MON-53 
  • Marcela Tamayo y Ortiz, ID, ScM, ScD

    “Prenatal exposure to stress modifies the association between prenatal lead and infant neurodevelopment”

    Oral presentation during Breakout 4: Novel strategies for prospective birth cohorts
  • Maria Skaalum Petersen, MSc, PhD

    “Spermatogenic capacity in fertile men with high exposure to polychlorinated biphenyls”

    Poster presentation number MON-62 
  • Rebecca M. Nachman, PhD, MPH

    “Individual and Joint Association of Exposure to Ambient PM2.5 and Ozone and Maternal Smoking with Preterm Birth in the Boston Birth Cohort”

    Oral presentation during Breakout 4: Novel strategies for prospective birth cohorts
  • Rebecca N. Bauer, PhD

    “In Utero Arsenic and Cadmium Exposure is Associated with Altered T lymphocyte Populations in Infant Cord Blood”

    Poster presentation number MON-6 
  • Shotaro Kawazoe

    “Effects of prenatal exposure to titanium dioxide nanoparticle on DNA methylation and gene expression profile in the brain of mouse”

    Poster presentation number MON-26 
  • Todd A Jusko, PhD,

    “Early life environmental exposures and reduced response to infant tuberculosis vaccination”

    Oral presentation during Breakout 3: Effects of developmental exposures on immune functions
  • Vinicius Carreira, DVM, DACVP

    “Cardiomyocyte-specific ablation of the aryl hydrocarbon receptor rescues the Nkx2-5 haploinsufficiency cardiac phenotype”

    Poster presentation number MON-1 

Presenting Tuesday, October 27

  • Anne G Hoen, PhD

    “Arsenic exposure, breast feeding and infant microbiome composition in a US birth cohort”

    Oral presentation during Breakout 7: Emerging concepts, new endpoints and methodologies
  • Deepti Sood

    “Exploring metabolic effects of prenatal POP exposure using metabolomics”

    Poster presentation number TUES-41 
  • Kevin Fournier

    “Derivation of cumulative toxicity indicators for indoor semi-volatile organic compounds: the case of reprotoxic and neurotoxic mixtures”

    Oral presentation during Breakout 6: Challenges in improving exposure assessments
  • Kristina Mattsson, MSc

    “Maternal smoking during pregnancy and offspring type 1 diabetes mellitus risk – accounting for HLA haplotype”

    Oral presentation during Breakout 5: Developmental exposures and diabetes pathogenesis
  • Maribel Casas, PhD

    “The correlation structure of the Pregnancy Exposome: multiple environmental exposures in the INMA-Sabadell Birth Cohort”

    Poster presentation number TUES-30 
  • Samantha L Kingsley, MPH

    “Proximity to major roadways and DNA methylation of repetitive elements in human placenta”

    Poster presentation number TUES-39
  • Syed Moshfiqur Rahman, BS

    “Effects of early life manganese exposure through drinking water on child growth and development”

    Poster presentation number TUES-49 
  • Sylvie Remy

    “Neonatal gene expression: Marks of prenatal exposure to PFOA, PFOS, PCB153, and DDE”

    Poster presentation number TUES-28
  • Vasilis G Moisiadis, BSc

    “Prenatal Synthetic Glucocorticoids and Multigenerational Paternal Programming of Offspring Behaviour and HPA Function”

    Oral presentation during Plenary IV: Developmental exposures and neurobehavioral disorders

Committee Support

Organizing Committee

  • Robert Barouki, MD, PhD, Université Paris Descartes Centre Universitaire des Saints Pères (France)
  • David C. Bellinger, PhD, Harvard School of Public Health
  • Ruth Etzel, MD, PhD, University of Wisconsin-Milwaukee Joseph J. Zilber School of Public Health
  • Philippe Grandjean, MD, DMSc, University of Southern Denmark/Harvard School of Public Health
  • Kimberly A. Gray, PhD, National Institute of Environmental Health Science/NIH
  • Jerrold (Jerry)  Heindel, PhD, National Institute of Environmental Health Sciences/NIH
  • Katherine (Katie) Herz, Harvard School of Public Health
  • Margaret R. Karagas, PhD, Dartmouth, Geisel School of Medicine
  • Toshihiro Kawamoto, MD, PhD, University of Occupational and Environmental Health (Japan)
  • Bruce P. Lanphear, MD, MPH, Simon Fraser University (Canada)
  • B. Paige Lawrence, PhD, University of Rochester Medical Center School of Medicine and Dentistry
  • Peter van den Hazel, MD, MPH, International Network for Children’s Health, Environment and Safety (The Netherlands)

Scientific Committee

  • Bruce Blumberg, PhD, University of California-Irvine
  • Ludwine Casteleyn, MD, University of Leuven (Belgium)
  • Sylvaine Cordier, PhD, DSc, Institut National de la Santé et de la Recherche Médicale (France)
  • Jordi Sunyer, MD, PhD, Centre for Research in Environmental Epidemiology (Spain)
  • Eun-Hee Ha, MD, PhD,  Ewha Womans University School of Medicine (Korea)
  • Juliette Legler, PhD, VU University Amsterdam (The Netherlands)
  • Sharon Munn, PhD, European Commission’s Joint Research Centre (Italy)
  • Katsuyuki Murata, MD, PhD, Akita University School of Medicine (Japan)
  • Emily Oken, MD, MPH, Harvard Medical School
  • Frederica  P. Perera, DrPH, PhD, Columbia University Mailman School of Public Health
  • Gail S. Prins, PhD, University of Illinois-Chicago
  • Alvaro Puga, PhD, University of Cincinnati
  • David H. Sherr, PhD, Boston University School of Public Health
  • Michael K. Skinner, PhD, Washington State University School of Biological Sciences
  • Peter D. Sly, MBBS, MD, FRACP, DSc, FThorSoc, The University of Queensland
  • William Suk, PhD, MPH, National Institute of Environmental Health Science/NIH
  • Jorma Toppari, MD, PhD, University of Turku (Finland)
  • Cheryl Lyn Walker, PhD, ATS, FAAAS, Texas A&M Health Science Center
  • Pál Weihe, MD, Faroese Hospital System (Faroe Islands)
  • Tracey J. Woodruff, PhD, MPH, University of California-San Francisco

Contact Us

For questions relating to PPTOX IV, please contact Dennis R. Harris, PhD, PPTOX IV Program Manager at the Endocrine Society by phone: +1.202.971.3612 or email: dharris@endocrine.org.

November 13 (Sun) - 16 (Wed), 2016